Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders

 
 

LEXICON PHARMACEUTICALS, INC. (LXRX) Add to portfolio

1m | 3m | 6m | 1y | 2y | 5y | 10y
Price: $3.89 Metrics
OS: 244.9 M
Market cap: $953 M
Net cash: $152 M $0.62 per share
EV: $800 M

 
TTM Valuation
EBITDA ($100) M
EBIT
EPS

Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20Dec-31-19Dec-31-18Dec-31-17Dec-31-16Dec-31-15
Revenues0.10.324.0322.163.291.779.3130.0
            Revenue growth-53.4%-98.8%-92.5%409.5%-31.1%15.7%-39.0%468.9%
Cost of goods sold0.00.01.93.22.51.9-207.10.0
Gross profit0.10.322.1318.860.789.8286.4130.0
            Gross margin100.0%100.0%92.0%99.0%96.1%97.9%361.3%100.0%
Research and development52.855.0153.691.9100.2152.2164.095.2
General and administrative48.132.347.256.863.866.143.223.8
EBIT-100.8-87.1-46.2170.1-103.3-130.6-127.211.0
            EBIT margin-72489.2%-29224.8%-192.5%52.8%-163.4%-142.5%-160.5%8.5%
Pre-tax income-101.9-87.8-58.6124.1-120.5-135.7-131.4-4.7
Income taxes0.00.00.0-6.00.0-12.70.00.0
            Tax rate0.0%0.0%0.0% 0.0%9.3%0.0%0.0%
Net income-101.9-87.8-58.6130.1-120.5-123.0-131.4-4.7
            Net margin-73341.0%-29449.0%-244.1%40.4%-190.7%-134.1%-165.8%-3.6%
 
Diluted EPS($0.62)($0.60)($0.53)$1.11($1.14)($1.17)($1.27)($0.05)
Shares outstanding (diluted)164.4146.3110.5116.7105.8105.2103.9103.6
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy